Canada markets open in 8 hours 21 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.70+0.79 (+5.30%)
At close: 04:00PM EDT
15.80 +0.10 (+0.64%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close14.91
Bid14.91 x 1400
Ask19.03 x 100
Day's Range14.80 - 17.40
52 Week Range3.53 - 17.40
Avg. Volume12,874,882
Market Cap2.313B
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-3.05
Earnings DateAug 06, 2024 - Aug 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00

    Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay

    After disappointing sales for their Covid vaccines last year, drugmakers are hoping for an August rollout of the updated shot.

  • Reuters

    Shah Capital ends campaign against Novavax board after Sanofi deal

    Under a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70 million at a lofty valuation. Novavax, which struggled to get its protein-based vaccine to the market in a timely manner, also removed a warning notice from February last year that raised doubts about it being in business after the deal. The fund, which owns an about 7.8% stake in Novavax, reiterated that the Sanofi agreement was a "long-awaited step in the right direction".

  • GlobeNewswire

    Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting

    Welcomes Recent Announcement by Novavax of Licensing Agreement with Sanofi Stresses Significant Value Still Remains to Be Unlocked at Novavax Still Believes Novavax Would Benefit from Stockholder Representative on Board RALEIGH, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Shah Capital Management, Inc. (together with its affiliates, “Shah Capital,” “we” or “our”) collectively beneficially owns ~7.9% of the outstanding common stock of Novavax, Inc. (NASDAQ: NVAX) (“Novavax” or the “Company”), making it